Blog

The Scottish Medicines Consortium has approved seven new medicines for use on NHS Scotland, including the first biologic treatment for ...

Scottish patients with cancer are still facing a treatment lottery despite promises to increase access to life-extending drugs, campaigners have warned. ...

The SMC has once again rejected a submission from MSD for Remicade (infliximab) for the treatment of moderately to severely ...

The Scottish Medicines Consortium has endorsed the use of seven new drugs on the National Health Service, including two biosimilars. ...

Below is a list of forthcoming submissions that have recently been added to the SMC work programme. ...

Seven new medicines have been accepted for use by the National Health Service in Scotland, including therapies for leukaemia, lung ...

[:content [\1 \7 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \T \h \e \  \c \o \s \t \space \o \f \space \p \r \e \s \c \r \i \b \i \n \g \space \d \r \u \g \s \space \i \n \space \S \c \o \t \l \a \n \d \space \h \a \s \space \i \n \c \r \e \a \s \e \d \space \b \y \space \Â \£ \6 \. \7 \space \m \i \l \l \i \o \n \space \i \n \space \a \space \y \e \a \r \. \  \P \a \y \m \e \n \t \s \space \t \o \space \p \h \a \r \m \a \c \i \s \t \s \, " ..."]]

[:content [\A \f \l \i \b \e \r \c \e \p \t \space \( \Z \a \l \t \r \a \p \) \  \i \s \space \n \o \t \space \r \e \c \o \m \m \e \n \d \e \d \space \f \o \r \space \u \s \e \space \w \i \t \h \i \n \space \N \H \S \space \S \c \o \t \l \a \n \d \space \f \o \r \space \u \s \e \  \i \n \space \c \o \m \b \i \n \a \t \i \o \n \space \w \i \t \h \space \i \r \i \n \o \t \e \c \a \n \/ \5 \- \f \l \u \o \r \o \u \r \a \c \i \l \/ \f \o \l \i \n \i \c \space \a \c \i \d \space \( \F \O \L \F \I \R \I \) \space \c \h \e \m \o \t \h \e \r \a \p \y \, \space \a \f \l \i \b \e \r \c \e \p \t \space \i \s \space \i \n \d \i \c \a \t \e \d " ..."]]

The Scottish Medicines Consortium has presented its latest recommendations which reveal backing for Novartis/ThromboGenics’ eye therapy Jetrea and Roche’s RoActemra ...

[:content [\1 \3 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  \F \r \o \m \space \6 \t \h \space \M \a \y \space \2 \0 \1 \4 \space \t \h \e \space \S \c \o \t \t \i \s \h \space \M \e \d \i \c \i \n \e \s \space \C \o \n \s \o \r \t \i \u \m \space \m \e \e \t \i \n \g \s \space \w \i \l \l \space \b \e \space \o \p \e \n \space \t \o \space \m \e \m \b \e \r \s \space \o \f \space \t \h \e \space \p \u \b \l \i \c " ..."]]

[:content [\1 \0 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \A \l \i \m \e \r \a \space \S \c \i \e \n \c \e \s \, \  \a \space \b \i \o \p \h \a \r \m \a \c \e \u \t \i \c \a \l \space \c \o \m \p \a \n \y \space \t \h \a \t \space \s \p \e \c \i \a \l \i \z \e \s \space \i \n \space \t \h \e \space \r \e \s \e \a \r \c \h \, \space \d \e \v \e \l \o \p \m \e \n \t \space \a \n \d \space \c \o \m \m \e \r \c \i \a \l \i \z \a \t \i \o \n \space \o \f \space \p \r \e \s \c \r \i \p \t \i \o \n \space \o \p \h \t \h \a \l \m \i \c \space \p \h \a \r \m \a \c \e \u \t \i \c \a \l \s \, \space \t \o \d \a \y " ..."]]

[:content [\3 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \  \P \a \t \i \e \n \t \s \space \a \n \d \space \d \o \c \t \o \r \s \space \i \n \space \S \c \o \t \l \a \n \d \space \a \r \e \space \t \o \space \h \a \v \e \space \a \space \g \r \e \a \t \e \r \space \s \a \y \space \o \v \e \r \space \w \h \i \c \h \space \d \r \u \g \s \space \f \o \r \space \r \a \r \e \space \c \o \n \d \i \t \i \o \n \s " ..."]]

[:content [\T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \S \e \p \t \e \m \b \e \r \space \2 \0 \1 \3 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]

[:content [\1 \7 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \  \T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]